Free Trial

Adaptimmune Therapeutics (ADAP) Insider Trading & Ownership

-0.04 (-3.81%)
(As of 05/23/2024 ET)

Adaptimmune Therapeutics (NASDAQ:ADAP) Insider Buying and Selling Activity

Insider Ownership
Number Of
Insiders Buying
(Last 12 Months)
Number Of
Insiders Selling
(Last 12 Months)
Amount Of
Insider Selling
(Last 12 Months)
Get ADAP Insider Trade Alerts

Want to know when executives and insiders are buying or selling Adaptimmune Therapeutics stock? Sign up for's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ADAP Insider Buying and Selling by Quarter

Adaptimmune Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/16/2024Adrian RawcliffeCEOSell9,304$0.79$7,350.16  
1/16/2024Elliot NorryInsiderSell2,287$0.79$1,806.73  
1/16/2024William C Bertrand JrCOOSell4,681$0.79$3,697.99  
1/12/2024William C Bertrand JrCOOSell5,220$0.85$4,437.00  
1/11/2024Adrian RawcliffeCEOSell11,945$0.84$10,033.80  
1/11/2024Elliot NorryInsiderSell4,009$0.84$3,367.56  
9/1/2023Adrian RawcliffeCEOSell2,403$0.78$1,874.34  
8/1/2023John LungerInsiderSell3,096$0.91$2,817.36  
7/10/2023Garry E MenzelDirectorSell47,702$0.91$43,408.82  
6/27/2023Adrian RawcliffeCEOSell2,333$0.92$2,146.36  
(Data available from 1/1/2013 forward)

ADAP Insider Trading Activity - Frequently Asked Questions

Who is on Adaptimmune Therapeutics's Insider Roster?

The list of insiders at Adaptimmune Therapeutics includes Adrian Rawcliffe, Cintia Piccina, Elliot Norry, Garry E Menzel, Gavin Wood, John Lunger, and William C Bertrand Jr. Learn more on insiders at ADAP.

What percentage of Adaptimmune Therapeutics stock is owned by insiders?

12.44% of Adaptimmune Therapeutics stock is owned by insiders. Learn more on ADAP's insider holdings.

Which Adaptimmune Therapeutics insiders have been selling company stock?

The following insiders have sold ADAP shares in the last 24 months: Adrian Rawcliffe ($89,940.76), Cintia Piccina ($22,234.30), Elliot Norry ($5,174.29), Garry E Menzel ($43,408.82), John Lunger ($28,254.56), and William C Bertrand Jr ($22,695.78).

How much insider selling is happening at Adaptimmune Therapeutics?

Insiders have sold a total of 166,757 Adaptimmune Therapeutics shares in the last 24 months for a total of $211,708.51 sold.

More Insider Trading Tools from MarketBeat

This page (NASDAQ:ADAP) was last updated on 5/23/2024 by Staff

From Our Partners